Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Wagner

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Journal of Cancer Research and Clinical Oncology|September 28, 2013
Everolimus as treatment for breast cancer patients with bone metastases only: results of the phase II RADAR studyNicolai Maass, Nadia Harbeck, Christoph Mundhenke, et al.
Oral Oncology|February 2, 2025
Histological and genetic criteria define a clinically relevant subgroup of HPV-positive oropharyngeal carcinomaMalte Suchan, Nora Wuerdemann, Steffen Wagner, et al.
The Plant Cell|March 1, 2023
SWEET11b transports both sugar and cytokinin in developing barley grainsVolodymyr Radchuk, Zeinu M Belew, Andre Gündel, et al.
Kidney International Reports|September 18, 2024
Timing and Modality of Kidney Replacement Therapy in Children and AdolescentsJulia Thumfart, Steffen Wagner, Marietta Kirchner, et al.
Nature Medicine|April 29, 2026
An agentic framework for autonomous scientific discovery in cancer pathologyFlorian Trost, Bide Zhang, Ines Aring, et al.
British Journal of Cancer|May 26, 2018
Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: a European Multicentre Study (OroGrams)Christian Grønhøj, David H Jensen, Christian Dehlendorff, et al.
NPJ Digital Medicine|August 19, 2023
Predicting HPV association using deep learning and regular H&E stains allows granular stratification of oropharyngeal cancer patientsSebastian Klein, Nora Wuerdemann, Imke Demers, et al.
The Lancet. Oncology|February 16, 2023
Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysisHisham Mehanna, Miren Taberna, Christian von Buchwald, et al.
International Journal of Cancer|May 29, 2019
Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancerKatrin Schmitt, Britta Molfenter, Natalia Koerich Laureano, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2024
TNM 8 staging system beyond p16: Double HPV/p16 status is superior to p16 alone in predicting outcome in oropharyngeal squamous cell carcinomaChristian von Buchwald, Kathrine Kronberg Jakobsen, Amanda-Louise Fenger Carlander, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Journal of Cancer Research and Clinical Oncology|September 28, 2013
Everolimus as treatment for breast cancer patients with bone metastases only: results of the phase II RADAR studyNicolai Maass, Nadia Harbeck, Christoph Mundhenke, et al.
Oral Oncology|February 2, 2025
Histological and genetic criteria define a clinically relevant subgroup of HPV-positive oropharyngeal carcinomaMalte Suchan, Nora Wuerdemann, Steffen Wagner, et al.
The Plant Cell|March 1, 2023
SWEET11b transports both sugar and cytokinin in developing barley grainsVolodymyr Radchuk, Zeinu M Belew, Andre Gündel, et al.
Kidney International Reports|September 18, 2024
Timing and Modality of Kidney Replacement Therapy in Children and AdolescentsJulia Thumfart, Steffen Wagner, Marietta Kirchner, et al.
Nature Medicine|April 29, 2026
An agentic framework for autonomous scientific discovery in cancer pathologyFlorian Trost, Bide Zhang, Ines Aring, et al.
British Journal of Cancer|May 26, 2018
Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: a European Multicentre Study (OroGrams)Christian Grønhøj, David H Jensen, Christian Dehlendorff, et al.
NPJ Digital Medicine|August 19, 2023
Predicting HPV association using deep learning and regular H&E stains allows granular stratification of oropharyngeal cancer patientsSebastian Klein, Nora Wuerdemann, Imke Demers, et al.
The Lancet. Oncology|February 16, 2023
Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysisHisham Mehanna, Miren Taberna, Christian von Buchwald, et al.
International Journal of Cancer|May 29, 2019
Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancerKatrin Schmitt, Britta Molfenter, Natalia Koerich Laureano, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2024
TNM 8 staging system beyond p16: Double HPV/p16 status is superior to p16 alone in predicting outcome in oropharyngeal squamous cell carcinomaChristian von Buchwald, Kathrine Kronberg Jakobsen, Amanda-Louise Fenger Carlander, et al.
Pageof 10